drugset / Trial / NCT01589666
Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
This study is a Phase 1, single-center, open-label, ascending dose study which will assess the safety and tolerability of 5 doses of spray-dried solvent/detergent treated plasma (Resusix®) in healthy volunteers.
Timeline
- Start
- 2013-11
- Primary completion
- 2016-09-09
- Completion
- 2016-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spray-dried S/D-treated Plasma | Unknown | 100 ml | — |
| Subject | Spray-dried S/D-treated Plasma | Unknown | 200 ml | — |
| Subject | Spray-dried S/D-treated Plasma | Unknown | 500 ml | — |
| Subject | Spray-dried S/D-treated Plasma | Unknown | 750 ml | — |
| Subject | Spray-dried S/D-treated Plasma | Unknown | 800 ml | — |